metaPreg - Flurazepam during pregnancy

Flurazepam updated on 02-10-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	1.04 [0.54, 1.99]	-	1 study	156,905	159	not evaluable	ROB	-
Congenital heart defects	0.84 [0.31, 2.25]	-	1 study	83,588	159	not evaluable	ROB	-
Major congenital malformations	1.04 [0.54, 1.99]	-	1 study	156,905	159	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	2.25 [0.47, 10.84]	58%	2 studies	45,219	28	not evaluable	ROB	-
Hide endpoints reported in only one study ...